Education
About Us
Working with TipRanks
Follow Us
Amplifon S.p.A. (IT:AMP)
:AMP
Top Page
Amplifon S.p.A.
(LSE:AMP)
60Neutral
Amplifon S.p.A. (AMP) vs. S&P 500 (SPY)
Market Cap
€3.92B
Dividend Yield1.67%
Average Volume (3M)1.18M
Price to Earnings (P/E)27.1
Beta (1Y)0.62
Revenue Growth6.60%
EPS Growth-6.47%
CountryIT
Employees13,195
SectorHealthcare
Sector Strength57
IndustryMedical Distributors
Share Statistics
EPS (TTM)0.64
Shares Outstanding226,388,630
10 Day Avg. Volume989,591
30 Day Avg. Volume1,184,004
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€25.58Price Target Upside46.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Amplifon S.p.A. Business Overview & Revenue Model
Company DescriptionAmplifon S.p.A. is a global leader in the hearing care retail sector, providing innovative hearing solutions and services. With an extensive network of points of sale, service centers, and affiliates across numerous countries, Amplifon offers a wide range of products including hearing aids, hearing protection devices, and related accessories. The company is dedicated to enhancing the quality of life for people with hearing impairments through personalized services and cutting-edge technology.
How the Company Makes MoneyAmplifon S.p.A. primarily makes money through the sale of hearing aids and related products. The company's revenue model is built around its extensive retail network, which includes direct points of sale and partnerships with independent businesses that offer Amplifon products. Key revenue streams include the sale of hearing aids, which are often customized to meet individual customer needs, and the provision of aftercare services and accessories. Significant partnerships with hearing aid manufacturers and healthcare providers also contribute to Amplifon's earnings by ensuring access to the latest technology and broadening the company's customer base. The company's focus on customer service and technological innovation further supports its financial performance by attracting and retaining clients seeking high-quality hearing solutions.
Amplifon S.p.A. Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 2.41B | 2.26B | 2.12B | 1.95B | 1.56B |
| Gross Profit | ||||
| 561.10M | 548.45M | 1.18B | 1.11B | 863.16M |
| EBIT | ||||
| 561.10M | 265.38M | 278.67M | 246.00M | 168.50M |
| EBITDA | ||||
| 376.43M | 522.01M | 513.82M | 468.72M | 361.67M |
| Net Income Common Stockholders | ||||
| 145.40M | 155.14M | 178.53M | 157.78M | 101.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 166.78M | 194.00M | 229.54M | 318.44M | 554.02M |
| Total Assets | ||||
| 0.00 | 3.69B | 3.58B | 3.52B | 3.23B |
| Total Debt | ||||
| 0.00 | 1.52B | 1.50B | 1.61B | 1.56B |
| Net Debt | ||||
| 0.00 | 1.32B | 1.32B | 1.34B | 1.02B |
| Total Liabilities | ||||
| -1.12B | 2.59B | 2.54B | 2.59B | 2.43B |
| Stockholders Equity | ||||
| 1.12B | 1.10B | 1.04B | 925.18M | 800.88M |
| Cash Flow | Free Cash Flow | |||
| 0.00 | 271.89M | 342.99M | 348.97M | 330.63M |
| Operating Cash Flow | ||||
| 0.00 | 413.54M | 458.62M | 462.37M | 391.47M |
| Investing Cash Flow | ||||
| 0.00 | -261.48M | -193.78M | -533.61M | -134.28M |
| Financing Cash Flow | ||||
| 0.00 | -135.06M | -353.80M | -208.64M | 151.52M |
Amplifon S.p.A. Technical Analysis
Neutral
17.43
Price Trends
19.86
Negative
22.73
Negative
24.89
Negative
Market Momentum
-0.82
Negative
43.29
Neutral
72.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AMP, the sentiment is Neutral. The current price of 17.43 is above the 20-day moving average (MA) of 17.27, below the 50-day MA of 19.86, and below the 200-day MA of 24.89, indicating a neutral trend. The MACD of -0.82 indicates Negative momentum. The RSI at 43.29 is Neutral, neither overbought nor oversold. The STOCH value of 72.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IT:AMP.
Amplifon S.p.A. Peers Comparison
Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | €10.88B | 26.10 | 23.48% | 2.34% | 12.45% | 6.76% | |
73 Outperform | €3.71B | 25.15 | 15.10% | 0.92% | 8.29% | 1.35% | |
62 Neutral | €335.44M | ― | -3.05% | ― | -7.31% | 63.18% | |
62 Neutral | €14.83B | 19.68 | 16.44% | 1.58% | 10.89% | 32.38% | |
60 Neutral | €3.92B | 27.07 | 12.92% | 1.67% | 6.60% | -6.47% | |
52 Neutral | $5.35B | 3.96 | -42.60% | 2.86% | 17.58% | 1.27% |
* Healthcare Sector Average
Performance Comparison
IT:AMP
Amplifon S.p.A.
17.43
-15.29
-46.73%
IT:REC
Recordati Industria Chimica e Farmaceutica SPA
52.70
3.55
7.23%
IT:IGD
IGD SIIIQ S.p.A.
3.04
1.34
79.25%
IT:PRY
Prysmian SpA
50.96
-0.15
-0.30%
IT:SOL
SOL SPA
40.95
7.69
23.11%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.